Keros Therapeutics News - KROS

Company Name	Stock Ticker Symbol	Market	Type
Keros Therapeutics Inc	KROS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-3.33	-5.78%	54.27	17:30:00

Open Price	Low Price	High Price	Close Price	Prev Close
58.06	53.59	58.425	54.27	57.60

more quote information »

Recent News

Date	Time	Source	Heading
5/08/2024	08:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/2024	08:01	EDGAR2	Form 8-K - Current report
5/08/2024	08:00	GLOBE	Keros Therapeutics Reports Recent Business Highlights and..
3/14/2024	08:00	GLOBE	Keros Therapeutics Announces U.S. FDA Fast Track Designation..
3/06/2024	08:01	EDGAR2	Form 8-K - Current report
3/05/2024	08:02	EDGAR2	Form 8-K - Current report
3/05/2024	08:01	EDGAR2	Form 8-K - Current report
3/05/2024	08:00	GLOBE	Keros Therapeutics to Present at Leerink Partners 2024..
2/28/2024	16:02	EDGAR2	Form 8-K - Current report
2/28/2024	16:01	GLOBE	Keros Therapeutics Reports Recent Business Highlights and..
2/23/2024	17:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/15/2024	20:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/15/2024	20:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/15/2024	20:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/15/2024	20:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/29/2024	08:00	GLOBE	Keros Therapeutics To Present at Pulmonary Vascular Research..
1/09/2024	08:01	EDGAR2	Form 8-K - Current report
1/09/2024	08:00	GLOBE	Keros Therapeutics Announces Closing of Upsized Public..
1/08/2024	16:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	16:04	EDGAR2	Form 8-K - Current report
1/04/2024	16:04	EDGAR2	Form 144 - Report of proposed sale of securities
1/04/2024	16:02	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/03/2024	21:29	GLOBE	Keros Therapeutics Announces Pricing of Upsized Public..
1/03/2024	16:05	GLOBE	Keros Therapeutics Announces Proposed Public Offering of..
1/03/2024	16:04	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/03/2024	08:04	EDGAR2	Form 8-K - Current report
12/11/2023	06:02	EDGAR2	Form 8-K - Current report
12/11/2023	06:00	GLOBE	Keros Therapeutics Presents Clinical Data from its KER-050..
11/07/2023	08:01	EDGAR2	Form 8-K - Current report
11/07/2023	08:00	GLOBE	Keros Therapeutics to Present at Upcoming Healthcare..
11/06/2023	08:11	EDGAR2	Form 8-K - Current report
11/06/2023	08:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/2023	08:01	EDGAR2	Form 8-K - Current report
11/06/2023	08:00	GLOBE	Keros Therapeutics Reports Recent Business Highlights and..
11/02/2023	09:00	GLOBE	Keros Therapeutics to Present at the 65th American Society..
10/04/2023	08:01	EDGAR2	Form 8-K - Current report
10/04/2023	08:00	GLOBE	Keros Therapeutics Presents Preclinical Data from its..
9/05/2023	08:02	EDGAR2	Form 8-K - Current report
9/05/2023	08:00	GLOBE	Keros Therapeutics to Present at Upcoming Healthcare..
8/07/2023	16:02	EDGAR2	Form 8-K - Current report
8/07/2023	08:04	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/2023	08:00	EDGAR2	Form 8-K - Current report
8/07/2023	08:00	GLOBE	Keros Therapeutics Reports Recent Business Highlights and..
7/27/2023	16:01	GLOBE	Corrected: Keros Therapeutics to Host Conference Call and..
7/24/2023	08:01	EDGAR2	Form 8-K - Current report
7/24/2023	08:00	GLOBE	Keros Therapeutics to Host Conference Call and Webcast to..
6/12/2023	08:00	GLOBE	Keros Therapeutics Announces Update to Participation at the..
6/09/2023	06:00	GLOBE	Keros Therapeutics Presents Clinical Trial and Preclinical..
6/07/2023	08:00	GLOBE	Keros Therapeutics to Present at Goldman Sach’s 44th Annual..
5/22/2023	09:00	GLOBE	Keros Therapeutics Presents Preclinical and Clinical Data..